Wedbush Securities Inc. increased its position in shares of CME Group Inc (NASDAQ:CME) by 11.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,151 shares of the financial services provider’s stock after acquiring an additional 642 shares during the quarter. Wedbush Securities Inc.’s holdings in CME Group were worth $1,194,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Truvestments Capital LLC acquired a new position in shares of CME Group during the first quarter valued at $32,000. Close Asset Management Ltd acquired a new position in CME Group in the first quarter valued at about $34,000. Advantage Investment Management LLC lifted its stake in CME Group by 119.0% in the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after buying an additional 100 shares during the period. Westside Investment Management Inc. acquired a new position in CME Group in the second quarter valued at about $38,000. Finally, Permanens Capital L.P. acquired a new position in CME Group in the first quarter valued at about $41,000. 84.44% of the stock is currently owned by institutional investors and hedge funds.

Shares of CME Group stock traded down $2.26 during trading hours on Wednesday, hitting $211.04. The company’s stock had a trading volume of 36,630 shares, compared to its average volume of 1,619,637. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $216.73. The stock has a 50 day simple moving average of $203.45. The company has a market capitalization of $75.44 billion, a P/E ratio of 30.88, a PEG ratio of 4.82 and a beta of 0.23. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company’s revenue for the quarter was up 20.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.74 earnings per share. As a group, research analysts anticipate that CME Group Inc will post 6.66 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. CME Group’s payout ratio is presently 43.99%.

Several equities analysts have weighed in on CME shares. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research note on Monday, May 27th. Deutsche Bank increased their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. ValuEngine raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Wells Fargo & Co increased their target price on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. Finally, UBS Group increased their target price on CME Group from $190.00 to $194.00 and gave the company a “neutral” rating in a research note on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $194.00.

In related news, Director Timothy S. Bitsberger sold 700 shares of the stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total transaction of $136,045.00. Following the completion of the transaction, the director now directly owns 9,421 shares in the company, valued at $1,830,971.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 1,132 shares of the stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $188.05, for a total value of $212,872.60. Following the transaction, the insider now owns 33,011 shares of the company’s stock, valued at $6,207,718.55. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 82,363 shares of company stock valued at $16,429,225. 1.20% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: Strike Price

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.